298 related articles for article (PubMed ID: 30911937)
1. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas.
Lei HM; Zhang KR; Wang CH; Wang Y; Zhuang GL; Lu LM; Zhang J; Shen Y; Chen HZ; Zhu L
Theranostics; 2019; 9(24):7122-7139. PubMed ID: 31695757
[No Abstract] [Full Text] [Related]
3. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
4. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
[TBL] [Abstract][Full Text] [Related]
5. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
Zhang R; Zhuang X; Zong L; Liu S; Liu Z; Song F
Anal Bioanal Chem; 2016 Aug; 408(21):5843-5854. PubMed ID: 27379392
[TBL] [Abstract][Full Text] [Related]
6. Metabolic signatures of four major histological types of lung cancer cells.
Lim SL; Jia Z; Lu Y; Zhang H; Ng CT; Bay BH; Shen HM; Ong CN
Metabolomics; 2018 Aug; 14(9):118. PubMed ID: 30830374
[TBL] [Abstract][Full Text] [Related]
7. Effect of
Nowacka M; Ginter-Matuszewska B; Świerczewska M; Sterzyńska K; Nowicki M; Januchowski R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328460
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Yassin Fel-Z
Pathol Res Pract; 2016 May; 212(5):398-409. PubMed ID: 26907783
[TBL] [Abstract][Full Text] [Related]
11. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
12. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
Miyata T; Oyama T; Yoshimatsu T; Higa H; Kawano D; Sekimura A; Yamashita N; So T; Gotoh A
Anticancer Res; 2017 May; 37(5):2541-2547. PubMed ID: 28476825
[TBL] [Abstract][Full Text] [Related]
14. Auramine O, an incense smoke ingredient, promotes lung cancer malignancy.
Tung JC; Huang WC; Yang JC; Chen GY; Fan CC; Chien YC; Lin PS; Candice Lung SC; Chang WC
Environ Toxicol; 2017 Nov; 32(11):2379-2391. PubMed ID: 28722353
[TBL] [Abstract][Full Text] [Related]
15. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
[No Abstract] [Full Text] [Related]
16. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve.
Yin J; Xie J; Guo X; Ju L; Li Y; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():428-435. PubMed ID: 27649503
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics.
Zhang P; Zhu W; Wang D; Yan J; Wang Y; He L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085117
[TBL] [Abstract][Full Text] [Related]
18. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice.
Le Y; Shen X; Kang H; Wang Q; Li K; Zheng J; Yu Y
J Mass Spectrom; 2018 Feb; 53(2):172-182. PubMed ID: 29160924
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole as a potent activator of human cytosolic aldehyde dehydrogenase ALDH1A1.
Calleja LF; Belmont-Díaz JA; Medina-Contreras O; Quezada H; Yoval-Sánchez B; Campos-García J; Rodríguez-Zavala JS
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129451. PubMed ID: 31678145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]